Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Use of Machine Learning and Lay Care Coaches to Increase Advance Care Planning Conversations for Patients With Metastatic Cancer.
Journal: JCO oncology practice
Published: November 17, 2022
Clinicopathologic characterization of enfortumab vedotin-associated cutaneous toxicity in patients with urothelial carcinoma.
Journal: Journal of the American Academy of Dermatology
Published: August 26, 2020
Physician preferences for non-metastatic castration-resistant prostate cancer treatment.
Journal: BMC urology
Published: October 04, 2019
Predicting Response to Immunotherapy by Evaluating Tumors, Lymphoid Cell-Rich Organs, and Immune-Related Adverse Events Using FDG-PET/CT.
Journal: Clinical nuclear medicine
Published: January 29, 2019
Erratum to "CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma" [Eur Urol 2017;72:962-71].
Journal: European urology
Published: January 08, 2018
CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma.
Journal: European urology
Published: September 21, 2016
Phase II Study of Pazopanib and Paclitaxel in Patients With Refractory Urothelial Cancer.
Journal: Clinical genitourinary cancer
Published: December 15, 2015
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.
Journal: The New England journal of medicine
Published: September 26, 2015
Immunohistochemical analysis of lichenoid reactions in patients treated with anti-PD-L1 and anti-PD-1 therapy.
Journal: Journal of cutaneous pathology
Published: September 13, 2015
Second-line therapies in metastatic urothelial carcinoma.
Journal: Hematology/oncology clinics of North America
Published: April 04, 2015
mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.
Journal: PloS one
Published: June 30, 2012
Last Updated: 09/26/2026